AWM
TMO icon

Atticus Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Atticus Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-357
Closed -$207K – 200
2025
Q4 		$207K Buy
+357
New +$202K 0.05% 196
2025
Q3 		– Sell
-205
Closed -$83.3K – 593
2025
Q2 		$83.3K Buy
205
+130
+173% +$54.4K 0.02% 268
2025
Q1 		$37.5K Sell
75
-45
-38% -$24.4K 0.01% 253
2024
Q4 		$62.6K Sell
120
-80
-40% -$44K 0.02% 222
2024
Q3 		$124K Sell
200
-62
-24% -$36.7K 0.04% 153
2024
Q2 		$145K Sell
262
-209
-44% -$120K 0.05% 135
2024
Q1 		$274K Sell
471
-130
-22% -$72.9K 0.09% 104
2023
Q4 		$319K Buy
601
+83
+16% +$40.2K 0.11% 93
2023
Q3 		$262K Hold
518
– – 0.1% 110
2023
Q2 		$270K Sell
518
-41
-7% -$22.1K 0.1% 113
2023
Q1 		$322K Sell
559
-36
-6% -$20.3K 0.12% 97
2022
Q4 		$328K Buy
595
+1
+0.2% +$530 0.13% 96
2022
Q3 		$322K Hold
594
– – 0.16% 90
2022
Q2 		$322K Sell
594
-26
-4% -$14.3K 0.13% 104
2022
Q1 		$366K Sell
620
-99
-14% -$56.9K 0.13% 102
2021
Q4 		$480K Sell
719
-183
-20% -$114K 0.19% 75
2021
Q3 		$516K Buy
902
+123
+16% +$67.5K 0.23% 57
2021
Q2 		$393K Buy
779
+27
+4% +$12.7K 0.17% 79
2021
Q1 		$343K Buy
752
+19
+3% +$9.07K 0.16% 80
2020
Q4 		$341K Buy
733
+177
+32% +$83K 0.17% 76
2020
Q3 		$246K Buy
556
+144
+35% +$59.5K 0.15% 76
2020
Q2 		$149K Buy
412
+408
+10,200% +$137K 0.1% 103
2020
Q1 		$1K Sell
4
-2
-33% -$631 ﹤0.01% 295
2019
Q4 		$2K Buy
+6
New +$1.82K ﹤0.01% 286

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Atticus Wealth Management's TMO Position: Q1 2026 in Review

Atticus Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 357 shares — an estimated $207K sold.

Atticus Wealth Management first reported a position in TMO in Q4 2019 and held it in 24 quarters. The position peaked at $516K in Q3 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Atticus Wealth Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Atticus Wealth Management sold 357 Thermo Fisher Scientific shares in Q1 2026, an estimated $207K.
  • Atticus Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 24 quarters.
  • Atticus Wealth Management's Thermo Fisher Scientific position peaked at $516K in Q3 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Atticus Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.